Clinical Trials Directory

Trials / Conditions / Higher-risk Myelodysplastic Syndrome

Higher-risk Myelodysplastic Syndrome

9 registered clinical trials studyying Higher-risk Myelodysplastic Syndrome — 4 currently recruiting.

StatusTrialSponsorPhase
RecruitingFirst-in-human (FIH) Trial of GEN3018 in Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML) or Higher-r
NCT07384715
GenmabPhase 1
Not Yet RecruitingAZA+Lus VS AZA Monotherapy in HR-MDS
NCT06927232
Peking Union Medical College HospitalPhase 3
RecruitingLisaftoclax (APG-2575) Combined With Azacytidine (AZA) in the Treatment of Patients With Higher-risk Myelodysp
NCT06641414
Ascentage Pharma Group Inc.Phase 3
TerminatedAMG 176 With Azacitidine in Subjects With Myelodysplastic Syndrome /Chronic Myelomonocytic Leukemia
NCT05209152
AmgenPhase 1
Active Not RecruitingStudy of 3D189 in Patients With Hematologic Malignancies
NCT05320809
3D MedicinesPhase 1
WithdrawnA Study of Bisantrene Combined With Cytarabine or With Decitabine for Adult Subjects With Extramedullary AML a
NCT05456269
Race Oncology LtdPhase 1
RecruitingStudy to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
NCT04068597
CellCentric Ltd.Phase 1 / Phase 2
CompletedNivolumab and Oral Cyclophosphamide for R/R AML and HIgh Risk MDS
NCT03417154
Masonic Cancer Center, University of MinnesotaPhase 2
UnknownDecitabine for Myelodysplastic Syndromes and Acute Myeloid Leukemia Before Allogeneic Hematopoietic Cell Trans
NCT01806116
The First Affiliated Hospital of Soochow UniversityPhase 4